Jiangsu Yahong Meditech Co., Ltd. (SHA:688176)
China · Delayed Price · Currency is CNY 14.20
-0.66 (-4.44%)
Mar 19, 2026, 3:00 PM CST
Jiangsu Yahong Meditech Revenue
In the year 2025, Jiangsu Yahong Meditech had annual revenue of 277.12M CNY with 37.49% growth. Jiangsu Yahong Meditech had revenue of 60.71M in the quarter ending December 31, 2025, a decrease of -3.03%.
Revenue
277.12M
Revenue Growth
+37.49%
P/S Ratio
28.82
Revenue / Employee
708.75K
Employees
399
Market Cap
7.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 277.12M | 75.56M | 37.49% |
| Dec 31, 2024 | 201.56M | 187.81M | 1,365.55% |
| Dec 31, 2023 | 13.75M | 13.73M | 52,604.89% |
| Dec 31, 2022 | 26.10K | 21.52K | 470.51% |
| Dec 31, 2021 | 4.57K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Neptunus Bioengineering | 27.28B |
| China Animal Husbandry Industry | 6.28B |
| Renhe Pharmacy Co.,Ltd | 3.76B |
| Jiangsu Kanion Pharmaceutical | 3.13B |
| Zhejiang Tianyu Pharmaceutical | 2.99B |
| Shandong Wit Dyne Health | 2.36B |
| Guangxi Wuzhou Zhongheng Group | 2.29B |
| Guilin Sanjin Pharmaceutical | 2.08B |